Kenvue Inc., the parent company of well-known brands such as Tylenol and Neutrogena, has recently reported disappointing sales figures, prompting increased scrutiny from investors and activists. The company’s organic sales grew by only 0.9 percent in the three months concluding on September 29, falling short of analysts’ expectations of 1.7 percent, as per Bloomberg data. […]
Report: Activist Investor Starboard Targets Neutrogena Owner Kenvue
In a significant development in the consumer products sector, hedge fund Starboard Value has acquired a stake in Kenvue, the parent company of well-known brands such as Band-Aid, Listerine, and Tylenol. This move comes at a challenging time for Kenvue, which has witnessed its stock price plummet by 18% since its IPO in May 2023. […]